Optipharm.CO.,LTD (KOSDAQ:153710)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,655.00
+90.00 (1.97%)
At close: Aug 24, 2026

Optipharm.CO.,LTD Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-2,115-2,499-2,357-2,437-2,045-3,080
Depreciation & Amortization
1,6791,6741,6141,4331,1201,076
Loss (Gain) From Sale of Assets
15.9316.24-0.97-1.06-3.051.76
Loss (Gain) From Sale of Investments
-132.68-175.23-185.27-184.65-346.47-90.2
Loss (Gain) on Equity Investments
---1.490.350.29
Stock-Based Compensation
646.07704.8587.33--33.61-5.9
Provision & Write-off of Bad Debts
-1.04-0.783.35-0.2-0.331.29
Other Operating Activities
438.58673.56480.51362.29298.11-1,063
Change in Accounts Receivable
1,885-504.72288.1476.25-899.4-95.74
Change in Inventory
-423.49-504.55-28.1-261.97-42.84-339.3
Change in Accounts Payable
29.324.48-89.16152.63-631.57226.52
Change in Other Net Operating Assets
-2,729-963.45-908.9-1,264187.121,399
Operating Cash Flow
-707.18-1,555-595.5-1,723-2,396-1,969
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,182-2,507-1,677-1,672-4,572-725.18
Sale of Property, Plant & Equipment
1.41.429.961.75.9311.81
Sale (Purchase) of Intangibles
-39.9-38.05-58.71-65.25-32.27-32.26
Investment in Securities
3,1513,2262,409-1,8542,621-6,789
Other Investing Activities
192.71131.02317.03--147.56
Investing Cash Flow
2,123813.611,020-3,589-1,978-7,387

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-10,31013,7007,7005,2005,100
Total Debt Issued
10,31010,31013,7007,7005,2005,100
Short-Term Debt Repaid
--10,750-12,560-5,560-3,560-3,560
Long-Term Debt Repaid
--163.73-197.01-147.29-130.41-156.45
Total Debt Repaid
-10,976-10,914-12,757-5,707-3,690-3,716
Net Debt Issued (Repaid)
-665.66-603.73942.991,9931,5101,384
Issuance of Common Stock
----250.5435
Other Financing Activities
---0-0-0-0
Financing Cash Flow
-665.66-603.73942.991,9931,7601,819

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Miscellaneous Cash Flow Adjustments
---0-0--
Net Cash Flow
750.31-1,3451,367-3,319-2,613-7,538

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1,889-4,062-2,273-3,395-6,968-2,695
Free Cash Flow Growth
------
Free Cash Flow Margin
-8.29%-18.18%-11.58%-19.54%-43.53%-18.90%
Free Cash Flow Per Share
-128.62-276.86-155.29-231.26-477.10-185.50
Levered Free Cash Flow
-468.97-2,578-1,010-2,006-6,486-2,171
Unlevered Free Cash Flow
-159.61-2,263-669.33-1,708-6,265-2,062

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
460.55382.85516.81463.38319.85158.37
Cash Income Tax Paid
--25.71-14.8936.5836.09-31.66
Change in Working Capital
-1,238-1,948-738.06-897.07-1,3871,190